Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?
Archives of Gynecology and Obstetrics · 2023
DOI: 10.1007/s00404-023-07103-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, 2023. Verfasst von Han Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Affiliated Hospital of Inner Mongolia Minzu University, Tongliao, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Fertility Preservation, Precancerous Conditions. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and Technology Plan of Liaoning Province, "1+X" plan project, the Scientific research funds of Liaoning Provincial Department of Education.
Abstract (Originalsprache)
Purpose
To determine the recurrence rate in the women with controlled ovarian hyperstimulation after a history of borderline ovarian tumors (BOT).
Methods
This was a retrospective analysis of 275 patients with BOT undergoing surgery for fertility preservation in our hospital between 2001 and 2017. Cases were divided into an assisted reproductive technology (ART) treatment group (n = 15) and a non-ART treatment group (n = 260). We compared the recurrence rate, survival rate and pregnancy outcomes between these two groups.
Results
The ART group had a higher recurrence rate (33.33% vs. 10.80%, P = 0.023). Survival analysis indicated that the recurrence time in patients undergoing ART was significantly shorter (P = 0.026). A low pregnancy rate before diagnosis, and high intraoperative blood loss, were associated with postoperative ART treatment (P < 0.05). Multivariate analysis showed that ART treatment and bilateral lesions both significantly increased the risk of recurrence (P < 0.05). The pathological type of recurrent tumors was often the same as the initial tumor.
Conclusion
The postoperative use of ART in patients with BOT significantly increased the recurrence rate, but does not significantly affect the overall survival rate of patients. Therefore, ART in such patients should be individualized, and close follow-up is necessary after ART.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Affiliated Hospital of Inner Mongolia Minzu University, Tongliao, China.
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Dalian Medical University, No. 467 Zhongshan Road, Shahekou District, Dalian City, 116027, Liaoning Province, China.
- Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Dalian Medical University, No. 467 Zhongshan Road, Shahekou District, Dalian City, 116027, Liaoning Province, China. non-aware@dmu.edu.cn.
Förderung
- the Science and Technology Plan of Liaoning Province
- "1+X" plan project
- the Scientific research funds of Liaoning Provincial Department of Education
- “1+X” plan project
Zitieren
APA
Gao, H., Wei, W., Li, Y., Wei, H., & Wang, N. (2023). Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-023-07103-8
Vancouver
Gao H, Wei W, Li Y, Wei H, Wang N. Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?. Archives of Gynecology and Obstetrics. 2023. doi:10.1007/s00404-023-07103-8
BibTeX
@article{Gao2023,
author = {Gao, Han and Wei, Wei and Li, Yibing and Wei, Heng and Wang, Ning},
title = {Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?},
journal = {Archives of Gynecology and Obstetrics},
year = {2023},
doi = {10.1007/s00404-023-07103-8}
}
EUVIMED